Graves Adrienne L 4
4 · Opus Genetics, Inc. · Filed Oct 24, 2024
Insider Transaction Report
Form 4
Graves Adrienne L
Director
Transactions
- Award
Stock Option (right to buy)
2024-10-22+172,874→ 172,874 totalExercise: $1.33Exp: 2034-10-21→ Common Stock (172,874 underlying)
Footnotes (1)
- [F1]The option will vest in a series of three equal annual installments over the three-year period measured from the grant date of October 22, 2024, subject to the Reporting Person's continuing service.